Unbiased News Awaits.
Published loading...Updated

Subcommittee discusses possible limits on proxy advisory companies

  • A Congressional subcommittee led by Rep. Ann Wagner held a hearing on April 29, 2025, to examine proxy advisory firms Glass Lewis and ISS, which control 97% of the market.
  • The hearing followed criticism and an investigation spurred by concerns over proxy firms' influence, conflicts of interest, and ESG and DEI policy enforcement, with competing views on the firms' roles.
  • Rep. Brad Sherman argued the firms serve investor clients who seek varied investment goals beyond profit, while critics like Jamie Dimon called the firms incompetent and urged their elimination.
  • Florida AG Uthmeier said proxy advisors have overwhelming power and must not impose partisan agendas, as his March investigation alleges violations of state antitrust and deceptive trade laws over ESG/DEI issues.
  • The subcommittee aims to improve the proxy process to advance long-term investor value and may consider regulatory changes amid Glass Lewis discussing ending voting recommendations amid political backlash.
Insights by Ground AI
Does this summary seem wrong?

26 Articles

All
Left
2
Center
6
Right
4
Wyoming Tribune EagleWyoming Tribune Eagle
+22 Reposted by 22 other sources
Center

Subcommittee discusses possible limits on proxy advisory companies

(The Center Square) – A Congressional subcommittee discussed Tuesday how to oversee proxy advisory companies that tell investors how to vote in corporate elections.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Aurinia Pharmaceuticals Inc. broke the news in on Tuesday, April 29, 2025.
Sources are mostly out of (0)

Similar News Topics